<DOC>
	<DOC>NCT00519259</DOC>
	<brief_summary>The purpose of this study is to assess safety and pharmacokinetics of sublingual lobeline in healthy normal volunteers.</brief_summary>
	<brief_title>Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1</brief_title>
	<detailed_description />
	<mesh_term>Lobeline</mesh_term>
	<criteria>Must be able to provide written informed consent Must have a body mass index between 18 and 30 Have no medical contraindications as determined by medical history, physical exam, ECG, hematology and blood chemistry profile, and urinalysis Must have a negative drug test at screening and admission If female of child bearing potential, must agree to use birth control Please contact the site for more information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2006</verification_date>
</DOC>